Rare Earth Nanoprobes for Targeted Delineation of Triple Negative Breast Cancer and Enhancement of Radioimmunotherapy
Advanced Science · 2024
DOI: 10.1002/advs.202309992 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2024. Verfasst von Zi-He Ming und 9 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Center and Department of Breast and Thyroid Surgery, Xiang'an Hospital of Xiamen University School of Medicine, Xiamen University, Xiamen, Fuj…. Hauptthemen laut MEDLINE: Triple Negative Breast Neoplasms, Radioimmunotherapy, Nanoparticles. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Young Elite Scientist Sponsorship Program by CAST, Fujian Major Scientific and Technological Special Project for Social Development, Start-up fund from the Third Affiliated Hospital of Kunming Medical University.
Abstract (Originalsprache)
Radiotherapy demonstrates a synergistic effect with immunotherapy by inducing a transformation of “immune cold” tumors into “immune hot” tumors in triple negative breast cancer (TNBC). Nevertheless, the effectiveness of immunotherapy is constrained by low expression of tumor‐exposed antigens, inadequate inflammation, and insufficient tumor infiltrating lymphocyte (TILs). To address this predicament, novel lutecium‐based rare earth nanoparticles (RENPs) are synthesized with the aim of amplifying radiation effect and tumor immune response. The nanoprobe is characterized by neodymium‐based down‐conversion fluorescence, demonstrating robust photostability, biocompatibility, and targetability. The conjugation of RENPs with a CXCR4 targeted drug enables precise delineation of breast tumors using a near‐infrared imaging system and improves radiation efficacy via lutetium‐based radio‐sensitizer in vivo. Furthermore, the study shows a notable enhancement of immune response through the induction of immunogenic cell death and recruitment of TILs, resulting in the inhibition of tumor progression both in vitro and in vivo models following the administration of nanoparticles. Hence, the novel multifunctional nanoprobes incorporating various lanthanide elements offer the potential for imaging‐guided tumor delineation, radio‐sensitization, and immune activation post‐radiation, thus presenting an efficient radio‐immunotherapeutic approach for TNBC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Cancer Center and Department of Breast and Thyroid Surgery, Xiang'an Hospital of Xiamen University School of Medicine, Xiamen University, Xiamen, Fujian, 361104, China.
- Fujian Key Laboratory of Precision Diagnosis and Treatment in Breast Cancer, Xiang'an Hospital of Xiamen University, Xiamen, Fujian, 361102, China.
- Xiamen Key Laboratory of Endocrine-Related Cancer Precision Medicine, Xiang'an Hospital of Xiamen University, Xiamen, Fujian, 361102, China.
- Xiamen Research Center of Clinical Medicine in Breast and Thyroid Cancers, Xiamen, Fujian, 361102, China.
- Department of Breast Center, Cancer Hospital of Shantou University Medical College, Shantou, Guangdong, 515041, China.
- State Key Laboratory of Structural Chemistry, Fujian Institute of Research on the Structure of Matter, Chinese Academy of Sciences, Fuzhou, Fujian, 350000, China.
ORCID-Profile: Zi-He Ming, Yun Zhang, Guo-Jun Zhang
Förderung
- Young Elite Scientist Sponsorship Program by CAST
- Fujian Major Scientific and Technological Special Project for Social Development
- Start-up fund from the Third Affiliated Hospital of Kunming Medical University
- Guangdong Basic and Applied Basic Research Foundation
- Fujian Science and Technology Innovation Laboratory for Optoelectronic Information of China
- National Natural Science Foundation of China
Zitieren
APA
Ming, Z. H., Zhang, Y. Q., Song, L., Chen, M., Lin, L. L., He, Y. Y., Liu, W. L., Zhu, Y. Y., Zhang, Y., & Zhang, G. J. (2024). Rare Earth Nanoprobes for Targeted Delineation of Triple Negative Breast Cancer and Enhancement of Radioimmunotherapy. Advanced Science. https://doi.org/10.1002/advs.202309992
Vancouver
Ming ZH, Zhang YQ, Song L, Chen M, Lin LL, He YY, et al. Rare Earth Nanoprobes for Targeted Delineation of Triple Negative Breast Cancer and Enhancement of Radioimmunotherapy. Advanced Science. 2024. doi:10.1002/advs.202309992
BibTeX
@article{Ming2024,
author = {Ming, Zi-He and Zhang, Yong-Qu and Song, Liang and Chen, Min and Lin, Lin-Ling and He, Yue-Yang and Liu, Wan-Ling and Zhu, Yuan-Yuan and Zhang, Yun and Zhang, Guo-Jun},
title = {Rare Earth Nanoprobes for Targeted Delineation of Triple Negative Breast Cancer and Enhancement of Radioimmunotherapy},
journal = {Advanced Science},
year = {2024},
doi = {10.1002/advs.202309992}
}
EUVIMED